3 to 5 years after the generic drug market from the oligarchs to long - Generics - pharmaceutical in

Read More About Business Ideas & Tips

"Brand Generic The popularity has also brought opportunities for Chinese enterprises. "China Pharmaceutical Industry Management Association at the Matilda in the November 17 meeting of the global simulation Beijing Pharmacy And opportunities for the Forum, said the past five years, the United States alone Sell Revenue of 820 billion patent Drugs Successively expired, Chinese enterprises should seize this opportunity.

The current global drug development at a standstill, a large number of patented drugs will soon expire, even if the original research and drug manufacturers have an advantage in price, but with the emergence of a large number of branded generic drugs, medicine has lost its original research, the global generic has entered the age of branding. Local enterprises should make great efforts to develop specialist generic brand, and take the road of integrating creative imitation. Despite the many opportunities for local businesses, but multinational corporations are expanding their own generics business to original research-based multinational drug major has its own generic brand. In addition, some companies through mergers and acquisitions are some good generic drug products to enrich its product line.

Foreign companies: the brand of generic drugs into the era of
According to statistics, by 2012 there will be 139 billion U.S. dollars in patent medicines lose patent protection, in this case, many large international Medicine The company decided to enter the field of generic drugs, as fast as many of the company's R & D to market changes, so have developed generic brands, in order to create a new business model. Some experts think that this is not just R & D problems, studies show that Financial Crisis, governments are the compressed medical expenses, so generic drugs have a better prospect. In addition, the transnational pharmaceutical companies face enormous pressure: First, the headquarters for the Chinese market has high expectations, many companies directly on their regional headquarters in China, because China's market share in the increasingly multinational business important role; Second, foreign pharmaceutical companies in the Chinese market share profits in the growing share of these enterprises are also found in other parts of its global product line growth has not met the expectations of the company's growth. Therefore, these enterprises focus has shifted to generic brands, vaccines and OTC products.

Drugs currently on the market can be divided into: innovative medicines, the original drug research, brand generic, non-branded generic drugs. Several categories of products from nearly 4 years compound rate of growth in foreign-funded enterprises accounted for 95% of the product the slowest growth of patent medicines in 2005, annual growth rate of 5% annual growth rate of 6% in 2006, 2007, annual growth rate 7%, unchanged from 2008. Generic brand fastest growing, 2005 to 2008, maintaining the growth rate of more than 40%. Rather than the price of branded generic drugs is declining, annual growth rate of 19% in 2005, 2006, 17% annual growth, annual growth rate of 16% in 2007, 2008, annual growth rate of 16%.

According to experts, the original patent expired edge research and medicine has become increasingly weak. In China, the price of the original study drug 4 times the price of other products, gross margin and the number is 5 times that of other enterprises. If not there is support for such a high profit, foreign companies can not hold 30% market share in China. This situation is different with the United States, many of the original study drug after the patent period, even if the price is not down, margins will be significantly reduced. And original research and drug treatment in China, priced separately and will not last long, as the disappearance of single pricing policy, foreign brand generic transition to the trend is clear.

Within the enterprise: based brand specialist
Recent years, the foreign original research of high drug prices are often equated with high quality, and even many in the industry believe that foreign-owned high-quality original research and medicine to enable consumers to pay higher prices. In experts, the foreign companies in China market advantage, does not depend on the quality. In fact, in a separate pricing policy, foreign companies the advantage of high profits, the ability to do more marketing, such as academic promotion, to influence the doctors hands "document." While domestic corporate profits lower generic drug, there is no capacity for large-scale marketing campaign. The marketing campaign is made of non-branded generic brand generic process.

According to reports, since the abolition of the OTC drugs in 2006 after the brand name, generic brand is more difficult for local enterprises had. Before generics can have their own brands, and even the same components can have different names. Since the SFDA implemented the management of generic drugs, this "brand game" era is over. But from another angle, whether or not the brand, these enterprises are in a competitive market, therefore, enterprises should build strengths in specialist areas, thereby creating the brand in a limited area.

Article Source: http://depositarticles.com/

I am a professional editor from China Product, and my work is to promote a free online trade platform. www.himfr.com/ contain a great deal of information about women's silk underwear , quarter cup bra welcome to visit!

Please Rate this Article

Not yet Rated

Click the XML Icon Above to Receive Business Ideas & Tips Articles Via RSS!

Additional Articles From - Home | Business | Business Ideas & Tips

Our other websites
All about SEO
Beauty Tips Forum

	Print This Article
	Post Comment
	Add To Favorites
	Email to Friends
	Ezine Ready

Submit Articles
Member Login
Link Us
Submission Guidelines
Ezine Notifications
Article RSS Feeds
Sitemap

New Stuff
About Us
Developer
Good shopping portal
Link to Us
Contact Us
Privacy Policy
Terms of Service